Ana Carolina Musser Tavares de Mattos1, Jano Alves de Souza1,2, Pedro Ferreira Moreira1,2, Mauro Eduardo Jurno1,3, Luis Guilhermo Coca Velarde4. 1. Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil. 2. Universidade Federal Fluminense, Departamento de Neurologia, Niterói RJ, Brasil. 3. Faculdade de Medicina de Barbacena, Departamento de Neurologia, Barbacena MG, Brasil. 4. Universidade Federal Fluminense, Instituto de Matemática e Estatística, Niterói RJ, Brasil.
Abstract
OBJECTIVE: To analyze the applicability of the Portuguese version of ID-MigraineTM in a sample of Brazilian patients. METHODS: Patients with headache were recruited from the neurology outpatient clinic of a tertiary hospital and submitted to the ID-MigraineTM questionnaire. The diagnosis of headache was made according to the ICHD-2 criteria. RESULTS: Of the 232 patients, 86% had migraine. The questionnaire showed a sensitivity of 92% (95%CI, 88% to 95%), specificity of 60% (95%CI, 43% to 77%) and a positive predictive value of 93% (95%CI, 89% to 96%). DISCUSSION: Our results were similar to other international studies of the ID-MigraineTM application. The Portuguese version is considered easy to use, and an appropriate screening tool for migraine diagnosis in our sample. CONCLUSION: Considering the characteristics of our health system, we can infer that this questionnaire would be beneficial in a Brazilian primary care setting; however, more studies are necessary.
OBJECTIVE: To analyze the applicability of the Portuguese version of ID-MigraineTM in a sample of Brazilian patients. METHODS: Patients with headache were recruited from the neurology outpatient clinic of a tertiary hospital and submitted to the ID-MigraineTM questionnaire. The diagnosis of headache was made according to the ICHD-2 criteria. RESULTS: Of the 232 patients, 86% had migraine. The questionnaire showed a sensitivity of 92% (95%CI, 88% to 95%), specificity of 60% (95%CI, 43% to 77%) and a positive predictive value of 93% (95%CI, 89% to 96%). DISCUSSION: Our results were similar to other international studies of the ID-MigraineTM application. The Portuguese version is considered easy to use, and an appropriate screening tool for migraine diagnosis in our sample. CONCLUSION: Considering the characteristics of our health system, we can infer that this questionnaire would be beneficial in a Brazilian primary care setting; however, more studies are necessary.
Authors: Hedwig A van der Meer; Corine M Visscher; Tom Vredeveld; Maria Wg Nijhuis van der Sanden; Raoul Hh Engelbert; Caroline M Speksnijder Journal: Cephalalgia Date: 2019-04-18 Impact factor: 6.292
Authors: Pedro Augusto Sampaio Rocha-Filho; Pedro Mota Albuquerque; Larissa Clementino Leite Sá Carvalho; Mylana Dandara Pereira Gama; João Eudes Magalhães Journal: J Headache Pain Date: 2022-01-03 Impact factor: 7.277